Genetics of Appendix Cancer Study

ConditionsAppendix Cancer Appendiceal Cancer Appendiceal Neoplasms Appendiceal Mucinous Neoplasm Appendiceal Adenocarcinoma Appendiceal Carcinoid Tumor Appendiceal Neoplasm Malignant Secondary Appendix Adenocarcinoma Appendix Mucinous Neoplasm Appendix Tumor Appendix Cancer Metastatic Appendix NET Low-Grade Appendix Mucinous Neoplasm High Grade Appendix Mucinous Neoplasm High Grade Appendix Mucinous Adenocarcinoma

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAndreana Holowatyj, PhD, MSCI

About this trial

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Eligibility criteria

Qualifiers

Known diagnosis of appendix cancer in the United States

Mentally and physically able to consent and participate in the study

Known diagnosis of appendix cancer

Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study

Disqualifiers

Women pregnant at the time of consent

Prisoners

Unable to provide informed consent

Unable to read, write, or complete questionnaires in English

Trial design

Treatments tested in this trial

Genetic profiling
Retrospective tissue procurement

Treatment groups

700 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Andreana Holowatyj, PhD, MSCI

Lead sponsor

Vanderbilt-Ingram Cancer Center

Sponsor institution

Source ClinicalTrials.gov